🇺🇸 FDA
Pipeline program

Platinum-based two drug chemotherapy (cisplatin/carboplatin + vinorelbine or cisplatin/carboplatin + pemetrexed regimen)

DLY201619

Phase 3 small_molecule terminated

Quick answer

Platinum-based two drug chemotherapy (cisplatin/carboplatin + vinorelbine or cisplatin/carboplatin + pemetrexed regimen) for Non-small Cell Lung Cancer Stage IIIA is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Non-small Cell Lung Cancer Stage IIIA
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials